slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 22,651-22,680
Pages 885
Rows per page 30
Arc
22,651-22,680 of 26,550
01
Eos Energy | Results Presentation Deck | 17 slidesEos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
02
Eos Energy | Results Presentation Deck | 17 slidesEos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
03
Eos Energy | Results Presentation Deck | 17 slidesEos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a 2x3 grid layout to present six distinct KPIs with supporting context.Eos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Operating Highlights1 hit
05
Includes a waterfall chart for cost reduction and a stacked bar chart for COGS breakdown.Eos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Operating Highlights1 hit
06
Eos Energy | Results Presentation Deck | 17 slidesEos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Complication1 hit
07
The slide uses a funnel-like progression structure to categorize commercial activity.Eos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Complication1 hit
10
Includes comparison of capex efficiency between current model and lithium-ion assembly.Eos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Evidence1 hit
11
The slide uses a visual of the battery assembly to map components to the supply chain table.Eos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Evidence1 hit
14
Includes a note about amounts marked '0' denoting less than $50,000.Eos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Satisfaction1 hit
15
Includes a footnote regarding rounding of values marked '0'.Eos Energy | Results Presentation Deck | 17 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Satisfaction1 hit
06
Uses a hub-and-spoke diagram to show the complexity of communication between carriers, forwarders, and importers/exporters.Freightos | Investor Presentation Deck | 37 slides · Freightos
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
The slide uses a process flow diagram to contextualize market segments within the Freightos ecosystem.Freightos | Investor Presentation Deck | 37 slides · Freightos
Pitch deck Investor relations Beat · Market Size1 hit
10
Uses the 'argument-from-analogy' framework by comparing their business model to Amadeus/Sabre and Booking.com/Expedia.Freightos | Investor Presentation Deck | 37 slides · Freightos
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
19
The slide uses a structured table to explain how network effects are scaled.Freightos | Investor Presentation Deck | 37 slides · Freightos
Pitch deck Investor relations Beat · Business Model1 hit
07
The slide uses a structural diagram to map technical modifications to clinical outcomes.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a comparison framework to contrast standard industry benchmarks with the company's clinical data.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
10
Includes a biological pathway diagram showing B-cell maturation and a pyramid diagram showing the hierarchy of disease targeting.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Includes a biological process diagram showing the interaction between NXC-201 CAR-T cells and disease-causing LLPC clones.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
Includes dot plot for BCMA expression, bar chart for IFNy activation, and flow cytometry plots showing cell elimination.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
Uses a bar chart to compare CRS duration in days across four competitors, with NXC-201 highlighted as significantly lower.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
The slide uses a bar chart to compare neurotoxicity percentages and a table to compare clinical metrics like CRS onset and duration.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
17
The slide uses a visual comparison between existing standard-of-care treatments (left) and the NXC-201 opportunity (center/right).Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
03
The slide uses a process-flow structure to connect the technology (LNCs) to current clinical validation (MAT2203) and future pipeline expansion.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
04
Includes scientific illustration of molecular structure and bulleted list of key benefits.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
05
The slide uses a two-part framework to explain the biological mechanism: Targeting (left) and Delivery (right).Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
06
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
07
Uses authority-citation to establish the urgency of the problem.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
Uses a before-after-bridge style logic to frame the solution.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
09
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit